We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
- Authors
Lacy, Mark D; Maguire, Jason D; Barcus, Mazie J; Ling, Judith; Bangs, Michael J; Gramzinski, Robert; Basri, Hasan; Sismadi, Priyanto; Miller, Gerri B; Chulay, Jeffrey D; Fryauff, David J; Hoffman, Stephen L; Baird, J Kevin
- Abstract
Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period. These subjects (3 atovaquone/proguanil recipients and 35 placebo recipients) were treated with 4 tablets of atovaquone/proguanil per day for 3 days. Atovaquone/proguanil provided safe, well-tolerated, and effective therapy for uncomplicated malaria in nonimmune Indonesians.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Vol 35, Issue 9, pe92
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/343750